Sapiens International Corp. announced Aug. 13 it entered into a definitive agreement for private equity investor Advent to acquire it for approximately $2.5 billion. Sapiens is a global leader in ...
The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol.